Protagenic Therapeutics, Inc.
PTIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,722 | $4,096 | $873 | $1,838 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $99 | $0 | $0 |
| Inventory | $1 | $1 | $0 | $0 |
| Other Curr. Assets | $135 | $0 | $0 | $0 |
| Total Curr. Assets | $2,858 | $4,331 | $928 | $1,883 |
| Property Plant & Equip (Net) | $51 | $64 | $60 | $73 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2,093 | $2,093 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$2,858 | $0 | $0 | $0 |
| Total NC Assets | -$714 | $2,157 | $60 | $73 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,145 | $6,488 | $989 | $1,956 |
| Liabilities | – | – | – | – |
| Payables | $1,641 | $2,084 | $165 | $103 |
| Short-Term Debt | $3,156 | $4,013 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6,547 | $3,860 | $0 | $0 |
| Total Curr. Liab. | $9,703 | $10,462 | $1,077 | $943 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,703 | $10,462 | $1,077 | $943 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$11,325 | -$10,455 | -$37,743 | -$36,303 |
| AOCI | $0 | -$258 | -$130 | -$130 |
| Other Equity | $3,766 | $0 | $0 | $0 |
| Total Equity | -$7,559 | -$3,974 | -$88 | $1,013 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,145 | $6,488 | $989 | $1,956 |
| Net Debt | $434 | -$83 | -$873 | -$1,838 |